EQUIP : Ensuring the Quality of Urinary Iodine Procedures
In 2001, the Centers for Disease Control and Prevention (CDC) established the EQUIP program to help laboratories worldwide assess the accuracy of their urinary iodine analysis and to provide them with technical support.CS120995Publication date from ...
core
Positive prognostic implications of SPHK1 expression in patients with papillary thyroid carcinoma undergoing radioactive iodine therapy. [PDF]
Park KW, Bae JS, Lim DJ, Jung CK.
europepmc +1 more source
Tongue and Nail Hyperpigmentation Following Radioactive Iodine Therapy: A Report of Two Cases. [PDF]
Regala C +7 more
europepmc +1 more source
Multifunctional Bismuth Nanoplatforms Augment Radioactive Iodine Therapy in Anaplastic Thyroid Cancer. [PDF]
Qu X +11 more
europepmc +1 more source
Clinical and metabolic factors associated with response to postoperative radioactive iodine therapy in Chinese obese patients with papillary thyroid carcinoma. [PDF]
Zhou Y +11 more
europepmc +1 more source
Analysis of the impact of Graves' disease on the efficacy of initial radioactive iodine therapy in patients with differentiated thyroid cancer. [PDF]
Wu P +6 more
europepmc +1 more source
Chronotherapeutic optimization of radioactive iodine therapy in differentiated thyroid cancer: The rationale for evening administration. [PDF]
Meristoudis G, Savvidis C, Ilias I.
europepmc +1 more source
Early predictors of 6-month thyroid-stimulating antibody levels after radioactive iodine therapy for Graves' disease: implications for pregnancy planning. [PDF]
Tachibana S +9 more
europepmc +1 more source
Multinodular Goiter: Diagnosis and Management [PDF]
Pickardt, C. R. +3 more
core +1 more source
Consideration of Radioactive Iodine Therapy in a Graves' Disease Patient with Secondary Psychosis: A Case Report. [PDF]
Sultan VU +3 more
europepmc +1 more source

